Capital Planning Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,802
| Closed | -$284K | – | 140 |
|
|
2024
Q2 | $284K | Sell |
4,802
-1,503
| -24% | -$94K | 0.05% | 118 |
|
|
2024
Q1 | $503K | Sell |
6,305
-421
| -6% | -$32.2K | 0.09% | 102 |
|
|
2023
Q4 | $531K | Sell |
6,726
-124
| -2% | -$8.82K | 0.1% | 97 |
|
|
2023
Q3 | $478K | Sell |
6,850
-20,437
| -75% | -$1.45M | 0.1% | 91 |
|
|
2023
Q2 | $1.89M | Sell |
27,287
-1,384
| -5% | -$98.5K | 0.38% | 55 |
|
|
2023
Q1 | $2.13M | Sell |
28,671
-13,850
| -33% | -$1.16M | 0.45% | 53 |
|
|
2022
Q4 | $3.96M | Buy |
42,521
+1,298
| +3% | +$125K | 0.94% | 30 |
|
|
2022
Q3 | $3.93M | Buy |
41,223
+1,173
| +3% | +$116K | 1.06% | 28 |
|
|
2022
Q2 | $3.71M | Buy |
40,050
+2,095
| +6% | +$204K | 0.98% | 27 |
|
|
2022
Q1 | $3.84M | Sell |
37,955
-355
| -0.9% | -$37.3K | 0.82% | 30 |
|
|
2021
Q4 | $3.95M | Buy |
38,310
+461
| +1% | +$42.6K | 0.75% | 35 |
|
|
2021
Q3 | $3.21M | Sell |
37,849
-736
| -2% | -$61.6K | 0.67% | 38 |
|
|
2021
Q2 | $3.22M | Buy |
38,585
+5,804
| +18% | +$475K | 0.66% | 38 |
|
|
2021
Q1 | $2.47M | Buy |
32,781
+3,556
| +12% | +$259K | 0.55% | 49 |
|
|
2020
Q4 | $2M | Sell |
29,225
-8,457
| -22% | -$550K | 0.49% | 50 |
|
|
2020
Q3 | $2.2M | Sell |
37,682
-4,670
| -11% | -$291K | 0.6% | 43 |
|
|
2020
Q2 | $2.75M | Buy |
42,352
+79
| +0.2% | +$4.97K | 0.82% | 36 |
|
|
2020
Q1 | $2.51M | Buy |
42,273
+194
| +0.5% | +$13K | 0.94% | 38 |
|
|
2019
Q4 | $3.13M | Buy |
42,079
+1,084
| +3% | +$76.1K | 0.82% | 46 |
|
|
2019
Q3 | $2.59M | Buy |
40,995
+33,586
| +453% | +$1.99M | 0.75% | 47 |
|
|
2019
Q2 | $404K | Buy |
+7,409
| New | +$399K | 0.12% | 95 |
|
|
2017
Q4 | – | Sell |
-38,269
| Closed | -$3.11M | – | 121 |
|
|
2017
Q3 | $3.11M | Buy |
38,269
+846
| +2% | +$66.9K | 1.22% | 19 |
|
|
2017
Q2 | $3.01M | Buy |
37,423
+7,226
| +24% | +$571K | 1.33% | 22 |
|
|
2017
Q1 | $2.37M | Buy |
30,197
+1,862
| +7% | +$149K | 1.17% | 21 |
|
|
2016
Q4 | $2.24M | Sell |
28,335
-5,045
| -15% | -$408K | 1.19% | 22 |
|
|
2016
Q3 | $2.97M | Buy |
33,380
+710
| +2% | +$67K | 1.59% | 19 |
|
|
2016
Q2 | $3.13M | Buy |
32,670
+205
| +0.6% | +$20.4K | 1.74% | 17 |
|
|
2016
Q1 | $3.37M | Buy |
32,465
+1,085
| +3% | +$106K | 1.62% | 16 |
|
|
2015
Q4 | $3.07M | Buy |
31,380
+2,075
| +7% | +$203K | 1.79% | 16 |
|
|
2015
Q3 | $2.83M | Buy |
29,305
+1,090
| +4% | +$115K | 1.86% | 16 |
|
|
2015
Q2 | $2.96M | Buy |
28,215
+5,935
| +27% | +$606K | 1.74% | 16 |
|
|
2015
Q1 | $2.3M | Buy |
22,280
+2,350
| +12% | +$238K | 1.6% | 18 |
|
|
2014
Q4 | $1.92M | Buy |
+19,930
| New | +$1.76M | 1.67% | 16 |
|
Other funds holding CVS
Capital Planning Advisors's CVS Position: Q3 2024 in Review
Capital Planning Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,802 shares — an estimated $284K sold.
Capital Planning Advisors first reported a position in CVS in Q4 2014 and held it in 33 quarters. The position peaked at $3.96M in Q4 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Capital Planning Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Capital Planning Advisors sold 4,802 CVS Health shares in Q3 2024, an estimated $284K.
- Capital Planning Advisors first reported a position in CVS Health in Q4 2014 and held it in 33 quarters.
- Capital Planning Advisors's CVS Health position peaked at $3.96M in Q4 2022.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Capital Planning Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.